Dell Inc. tells suitors Carl Icahn and Southeastern Asset Management that the company would not provide more information about itself.» Read More
In what may be a "vote of confidence" in Kraft Foods' turnaround strategy, Warren Buffett's Berkshire Hathaway has acquired a "small stake" in the company, according to the Wall Street Journal. The paper quotes a "person familiar with Berkshire's share purchase" as saying it represents less than 5% of Kraft's $55 billion market capitalization.
Billionaire investor Carl Icahn does not hold shares in Korea's Samsung Electronics and has no plans to bid for the company, contrary to press speculation in the last week, an Icahn representative said on Tuesday.
Shareholders of auto supplier Lear rejected a $2.9 billion buyout offer Monday from a firm led by billionaire investor Carl Icahn. Icahn's American Real Estate Partners had sweetened its offer to $37.25 per share for the auto parts supplier, but at Monday's meeting in Wilmington, Del., some shareholders said Lear was worth far more.
Billionaire investor Carl Icahn has taken a stake in Kraft Foods, according to The Wall Street Journal.
Billionaire investor Carl Icahn's American Real Estate Partners raised its takeover offer for Lear to about $3 billion after shareholders balked at a previous buyout proposal, but the auto parts maker's second biggest shareholder remained unconvinced.
Billionaire corporate raider Carl Icahn, the man famed for hostile takeover battles for names such as TWA and RJR Nabisco, said Wednesday that the escalating amount of private-equity deals rushing the market this year has peaked.
Wall Street’s is a fashion show, and the best traders in the market choose what’s hot or not. So the strategy is to figure out which stock will walk the runway next.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Two funds are leading a charge to overturn the rules that require them to file quarterly holdings information, maintaining that such disclosures are trade secrets.
Investor Carl Icahn has purchased a big stake in Anadarko Petroleum, according to regulatory filings, suggesting the billionaire investor is betting on further consolidation in the oil services sector.
The founder and former CEO of ImClone Systems, Sam Waksal, who is now sitting in prison for his role in the trading scandal that ensnared Martha Stewart, had a reputation for rubbing elbows with the New York glitterati and the Hollywood set. Well, it looks like ImClone is reliving its past.
The cable industry is assembling in Las Vegas for a major convention, where competition, convergence and content are the buzz words.
Carl Icahn on Monday failed to win a seat on the board of Motorola the company said, after a bitter proxy battle between the billionaire investor and the mobile phone maker.
Mobile phone maker Motorola said on Monday that it believes its shareholders did not elect billionaire investor Carl Icahn to the company's board, and that current members were reelected.
Billionaire investor Carl Icahn appears to have a good chance of succeeding in his high-profile bid for a board seat at Motorola, portending trouble for Chief Executive Ed Zander, analysts and investors said this week.
Responding to Carl Icahn's interview on CNBC Wednesday, Motorola sent another letter to stockholders urging them to vote against the billionaire financier's effort to gain a seat on the cell-phone maker's board.
In an exclusive interview on CNBC, Billionaire investor Carl Icahn lashed back at Motorola, calling the company's management "terrible" and saying "earnings were so bad that the company had no measure of what they were doing."
Activist investor Carl Icahn is stepping up his campaign to get a seat on Motorola's board, according to a report on The Wall Street Journal's Web site on Tuesday.
Bristol-Myers Squibb announced today a potential $1 billion partnership deal with the biggest pharmaceutical company in the world, Pfizer, on a clot-busting drug. And there are signals that its older, troubled partnership with ImClone Systems could be in for some reconciliation.Shares of IMCL were down after the company reported that sales of the cancer drug it markets with BMY, Erbitux, climbed 16% in the first quarter, but fell short of the analyst consensus by $5 million.
Billionaire investor-activist Carl Icahn, who is seeking a seat on Motorola's board, said Wednesday that proxy voting adviser Institutional Shareholder Services has recommended the cell phone maker's investors elect him.
Billionaire investor Carl Icahn said Monday he no longer intends to put forth an opposition slate of directors at MedImmune's upcoming annual meeting after the biotechnology company announced last week it is exploring a sale.